#lentiviral vector — Wednesday, April 01, 2026 (1 items)
| 0 | 💬 0 |
In vivo generation of anti-BCMA CAR-T cells in relapsed or refractory multiple myeloma: a phase 1 study.
(nature.com)
|
Nature Medicine 2026-04-01 | #immunotherapy #car-t #multiple myeloma #cytokine release syndrome #lentiviral vector |